This week's topics include a genetic treatment for hypercholesterolemia, cannabis and hyperemesis, reducing the risk of dementia, and a newer anti-inflammatory for PMR.

This week's topics include caffeine's impact on CVD, antihistamines and atopic dermatitis, a community designed diet for heart failure, and e-cigarettes after smoking cessation.

This week's topics include circular RNA to diagnose Alzheimer's disease, a new agent for acute pain, trends in alcohol consumption in pregnant women, and diagnosing non-alcoholic fatty liver disease.

This week's topics include GLP1s and AUD, impact of CVD risk calculation, meeting lipid lowering targets, and no luck with a vaccine for gonorrhea.

This week's topics include continuing dual antiplatelet therapy after stenting, amyloid depletion in Alzheimer's, infections in US hospitals, and algorithms for diagnosing PE in people with cancer.

This week's topics include a dual-action prosthesis for hip replacement, a new inhaled agent for idiopathic pulmonary fibrosis, testing nursing home residents for respiratory viruses, and online GLP-1 prescribing.

This week's topics include technology to improve stroke outcomes, adult use of social media and health decisions, impact of social media ban on Australian youth, and an LLM to augment clinical management in a low resource setting.

This week's topics include patellar resurfacing with TKR, long-term outcome for CAR-Ts, tranexamic acid in routine surgery, and patient messaging trends.

This week's topics include SES and brain development in kids, lifestyle changes and multimobidity, food labeling and childhood obesity, and prehabilitation in elders.

This week's topics include visceral fat and CVD risk factors, delirium and cognitive decline and hospitalization, caps on insulin price, and factors involved with IBD.